臨床試驗

CVT-ISR First in Human Trial for Coronary In-Stent Restenosis

NCT：NCT05731700 · COMPLETED

NCT IDNCT05731700

狀態COMPLETED

開始日期2021-10-20

完成時間2025-05-08

SponsorAbbott Medical Devices (INDUSTRY)

First posted2023-02-16

Last updated2026-05-15

簡要摘要

The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。